Printer Friendly

THERMO CARDIOSYSTEMS ANNOUNCES FIRST QUARTER RESULTS

 THERMO CARDIOSYSTEMS ANNOUNCES FIRST QUARTER RESULTS
 WOBURN, Mass., May 4 /PRNewswire/ -- Thermo Cardiosystems Inc. (AMEX: TCA) today reported revenues of $419,000 for the quarter ended March 28, 1992, compared with $429,000 for 1991. Net loss for the quarter was $139,000, compared with a net loss of $229,000 in the same quarter last year.
 "Product revenues from our HeartMate(R) ventricular-assist devices (VADs) were $412,000 for the first quarter, more than twice last year's first quarter product revenues of $183,000," said Victor L. Poirier, president and chief executive officer of Thermo Cardiosystems. "Our increased product revenues have offset the sharp drop in contract research and development revenues. Our clinical investigations continue to produce positive results -- in fact, there are now two patients in Texas who walk freely around the hospital with the battery-powered version of our HeartMate VAD."
 Thermo Cardiosystems Inc. is a leader in research and development of implantable ventricular-assist devices. These devices are designed to perform substantially all or part of the pumping function of the left ventricle of the natural heart for patients suffering from cardiovascular disease. The company's devices are currently intended for investigational use only. Thermo Cardiosystems is a public subsidiary of Thermedics Inc. (AMEX: TMD) and Thermo Electron Corporation (NYSE: TMO).
 THERMO CARDIOSYSTEMS INC.
 Financial Highlights
 $429,000
 Loss Before Income Taxes (134,000) (245,000)
 Net Loss (139,000) (229,000)
 Loss Per Share (.02) (.03)
 Weighted Average Shares 8,625,000 8,625,000
 -0- 5/4/92
 /CONTACT: John N. Hatsopoulos of Thermo Cardiosystems, 617-622-1111/
 (TCA TMD TMO) CO: Thermo Cardiosystems, Inc. ST: Massachusetts IN: MTC SU: ERN


SH -- NE021 -- 6011 05/04/92 11:58 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 4, 1992
Words:281
Previous Article:CONSUL RESTAURANT CORPORATION, UNSECURED CREDITORS ANNOUNCE JOINT PLAN OF REORGANIZATION
Next Article:INTERVIEW/DEMONSTRATION OPPORTUNITY: INTERACTIVE TELEVISION INDUSTRY UNDERGOING MAJOR CHANGES


Related Articles
THERMO CARDIOSYSTEMS INC. ANNOUNCES THIRD QUARTER RESULTS
THERMO CARDIOSYSTEMS INC. ANNOUNCES SECOND QUARTER RESULTS
HEARTMATE TO BE FIRST IMPLANTABLE CARDIAC-ASSIST DEVICE USED IN JAPAN
THERMO CARDIOSYSTEMS INC. ANNOUNCES THIRD QUARTER RESULTS
THERMO CARDIOSYSTEMS INC. ANNOUNCES FIRST QUARTER RESULTS
THERMO CARDIOSYSTEMS INC. ANNOUNCES SECOND QUARTER RESULTS
THERMO CARDIOSYSTEMS INC. ANNOUNCES FIRST QUARTER RESULTS
THERMO CARDIOSYSTEMS INC. ANNOUNCES RECORD QUARTERLY RESULTS
Thermo Cardiosystems Expects Fourth Quarter Revenues To Exceed Prior 1997 Quarters
Thermo Cardiosystems and Thoratec Laboratories Announce Merger Agreement.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters